Electrophysiology Devices Market Deep Analysis by Production Overview and Insights 2027

High prevalence of cardiovascular disease is fostering the growth of the global electrophysiology devices market

  1. 1. In April 2019, VivaQuant, a digital health company, received the U.S. FDA clearance for its RX-1 wearable device which will operate as a Holter monitor

  2. 2. In February 2020, Johnson & Johnson launched a replacement , virtual clinical study to work out the efficacy of Apple’s iPhone and ECG-enabled smartwatch in reducing the danger of stroke and detecting cases of fibrillation

  3. . In November 2019, Bittium Corporation, a Finland-based cardiology, and neurology device company, presented Bittium HolterPlus, a web-based remote cardiac monitoring solution, consisting of a Bittium Faros ECG device and Bittium HolterPlus mobile application, at Medica 2019
  4. 4. In January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient monitoring, received the U.S. FDA clearance for its Continuous ECG platform comprising of reusable wearable ECG sensors and associated software development kit.

  5. 5. In April 2021, American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant Registry as a part of its National Cardiovascular Data Registry (NCDR).

  6. 6. In May 2019, Johnson & Johnson Medical Devices Companies launched Biosense Webster Inc.’s CARTONET as a part of the company’s mission to assist revolutionize the way electrophysiologists and researchers leverage and share data with the goal of improving patient outcomes and operational efficiency in catheter ablation procedures.

The PDF for the study can be requested using the following link:

The growing prevalence of the disorder is primarily fueling the expansion of the worldwide electrophysiology devices market. consistent with the U.S. Department of Health & Human Services, heart condition is that the leading explanation for death for men, women, and other people of most racial and ethnic groups within the us . One person dies every 36 seconds within the us from disorder . About 655,000 Americans die from heart condition each year—that’s 1 in every 4 deaths. Also, the growing geriatric population is further projected to spice up demand for electrophysiology devices. consistent with the U.S. Bureau of the Census , the U.S. geriatric population is predicted to succeed in 77 million by 2034.

On the opposite hand, recall of devices is projected to limit the expansion of the worldwide electrophysiology devices market. as an example , in February 2019, Medtronic Plc received an FDA product recall for implanted cardiac pacemakers, which affected 13,440 devices manufactured and distributed between March 2017 and January 2019

North America is predicted to dominate the worldwide electrophysiology devices market and this is often attributed to the presence of a well-established healthcare sector and therefore the increasing launch of innovative products within the region. as an example , in June 2020, Boston Scientific announced the U.S. launch of the DIRECTSENSE™ Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures.

Competitive Landscape

Major players operating in the Global Electrophysiology Devices Market include, GE Healthcare, Biotricity Inc., Medtronic Plc, VivaQuant, Johnson & Johnson, AliveCor, Bittium Corporation, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corp., MicroPort, Philips Healthcare, and Siemens Healthcare.

“Limited Time Offer”

We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027


About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformation growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Related Articles

Back to top button